Literature DB >> 31205241

Why Should We Advocate Maternal Immunization?

Jim Boonyaratanakornkit1, Helen Y Chu.   

Abstract

Maternal vaccination provides a method for protecting the pregnant woman, fetus and neonate during a period when there is increased susceptibility to infectious diseases. A dynamic state of immune tolerance during pregnancy and the need to develop adaptive memory to a new foreign antigen-rich environment lead to windows of vulnerability to infection for the mother and neonate, respectively. Passive transfer of humoral immunity through the placenta and breast milk from the mother can bridge the gap in immunity for the neonate. Studies on boosting this natural process of antibody transfer have led to the recommendation for administering inactivated influenza, diphtheria, tetanus toxoid and acellular pertussis vaccines during pregnancy. Several new maternal vaccine candidates are on the horizon.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31205241      PMCID: PMC6581206          DOI: 10.1097/INF.0000000000002312

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  60 in total

1.  Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009.

Authors:  Pedro L Moro; Karen Broder; Yenlik Zheteyeva; Kimp Walton; Patricia Rohan; Andrea Sutherland; Alice Guh; Penina Haber; Frank Destefano; Claudia Vellozzi
Journal:  Am J Obstet Gynecol       Date:  2010-10-20       Impact factor: 8.661

2.  Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.

Authors:  Justin M Richner; Brett W Jagger; Chao Shan; Camila R Fontes; Kimberly A Dowd; Bin Cao; Sunny Himansu; Elizabeth A Caine; Bruno T D Nunes; Daniele B A Medeiros; Antonio E Muruato; Bryant M Foreman; Huanle Luo; Tian Wang; Alan D Barrett; Scott C Weaver; Pedro F C Vasconcelos; Shannan L Rossi; Giuseppe Ciaramella; Indira U Mysorekar; Theodore C Pierson; Pei-Yong Shi; Michael S Diamond
Journal:  Cell       Date:  2017-07-13       Impact factor: 41.582

3.  Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy.

Authors:  A Malek; R Sager; H Schneider
Journal:  Am J Reprod Immunol       Date:  1994-08       Impact factor: 3.886

Review 4.  Status of vaccine research and development of vaccines for GBS.

Authors:  Paul T Heath
Journal:  Vaccine       Date:  2016-03-15       Impact factor: 3.641

5.  Elevation of cord over maternal IgG immunoglobulin: evidence for an active placental IgG transport.

Authors:  P F Kohler; R S Farr
Journal:  Nature       Date:  1966-06-04       Impact factor: 49.962

Review 6.  Pregnancy and infection.

Authors:  Athena P Kourtis; Jennifer S Read; Denise J Jamieson
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

7.  Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada.

Authors:  Lynda K Mikelova; Scott A Halperin; David Scheifele; Bruce Smith; Elizabeth Ford-Jones; Wendy Vaudry; Taj Jadavji; Barbara Law; Dorothy Moore
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

8.  HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Authors:  Jennifer Mabuka; Ruth Nduati; Katherine Odem-Davis; Dylan Peterson; Julie Overbaugh
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

Review 9.  Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy.

Authors:  Christopher R Wilcox; Beth Holder; Christine E Jones
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

10.  Impact of Timing of Influenza Vaccination in Pregnancy on Transplacental Antibody Transfer, Influenza Incidence, and Birth Outcomes: A Randomized Trial in Rural Nepal.

Authors:  Joanne Katz; Janet A Englund; Mark C Steinhoff; Subarna K Khatry; Laxman Shrestha; Jane Kuypers; Luke C Mullany; Helen Y Chu; Steven C LeClerq; Naoko Kozuki; James M Tielsch
Journal:  Clin Infect Dis       Date:  2018-07-18       Impact factor: 9.079

View more
  2 in total

Review 1.  Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper.

Authors:  Susanna Esposito; Bahaa Abu-Raya; Paolo Bonanni; Fabianne Cahn-Sellem; Katie L Flanagan; Federico Martinon Torres; Asuncion Mejias; Simon Nadel; Marco A P Safadi; Arne Simon
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

Review 2.  The journey to a respiratory syncytial virus vaccine.

Authors:  Asuncion Mejias; Rosa Rodríguez-Fernández; Silvia Oliva; Mark E Peeples; Octavio Ramilo
Journal:  Ann Allergy Asthma Immunol       Date:  2020-03-23       Impact factor: 6.347

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.